• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Health | News, Analysis, Insights - HIT Consultant

SimonMed Integrates Siemens Healthineers Ultrasound for Enhanced Liver Disease Detection

by Syed Hamza Sohail 01/16/2025 Leave a Comment

SimonMed Integrates Siemens Healthineers Ultrasound for Enhanced Liver Disease Detection

What You Should Know: -       Siemens Healthineers, a leading global medical technology company operating in over 180 countries, is pioneering breakthroughs in healthcare through innovation and sustainability. With approximately 71,000 employees, Siemens Healthineers generated €21.7 billion in revenue in fiscal 2023. -       The company focuses on imaging, diagnostics, cancer care, and minimally invasive therapies, enhanced by
Read More

Overprescribing and Polypharmacy: Arine CEO Talks The Hidden Dangers of Amazon’s Same-Day Prescription Delivery

by Fred Pennic 01/15/2025 Leave a Comment

As ultra-fast prescription delivery services reshape medication access, healthcare providers face an urgent challenge: balancing patient convenience with medication safety. With 1 in 5 adults using five or more prescription drugs and medication-related problems consuming 1 in 6 healthcare dollars ($528B annually), the stakes are high. In this interview, Yoona Kim, CEO of healthcare AI company Arine discusses how the evolution of prescription delivery services, while improving access, may inadvertently contribute to dangerous polypharmacy and medication mismanagement. She comments on the critical challenges facing healthcare providers, from fragmented medication tracking to rapidly evolving drug knowledge, and explores how AI-powered solutions can help ensure safe, effective medication management in an increasingly automated healthcare landscape. What are the potential benefits and risks of ultra-fast prescription delivery services like Amazon Pharmacy's same-day delivery? How can these services impact patient access to medications and adherence to treatment plans? Yoona Kim, Founder & CEO at Arine: Ultra-fast prescription delivery services like Amazon Pharmacy’s same-day delivery offer clear benefits to patients, particularly those with acute health needs. Instead of having to pick up medication from the pharmacy – while potentially feeling under the weather – patients can have medications delivered straight to their door within hours. It’s easy to see why this level of convenience is appealing, especially as we grow accustomed to rapid delivery in other areas of our lives, such as grocery shopping. However, this convenience comes with considerable risks in our already fragmented healthcare ecosystem. To start, it complicates providers’ ability to track a patient’s medications. People often, and erroneously, assume that healthcare providers have a clear, comprehensive picture of a patient’s prescriptions, but that’s not usually the case. For example, when someone is admitted to the hospital, their doctors need to piece together their medication history, often by conducting a medication review with the patient, calling their PCP, consulting specialists, and sometimes reaching out to family members. Even with those efforts, up to two-thirds of hospital patients have something missing or incorrect in their medication records, which can lead to risky drug interactions. In addition, patients are often confused by their medications. For these individuals, having an additional interaction with a pharmacist can be invaluable. As medication therapies become more complex, the role of pharmacists has expanded beyond simply dispensing, to educating patients around safe medication use, and warning them about drug interactions. When this touchpoint is removed, patients may lose an opportunity for crucial medication counseling. So while Amazon’s prescription delivery might be a game-changer when it comes to convenience and speed, we do need to ensure that it isn’t hindering providers’ ability to quickly access accurate medication information, and not preventing patients’ access to comprehensive medication counseling. Could these services' convenience and speed inadvertently contribute to overprescribing and polypharmacy? If so, how? Yoona Kim: While the convenience and speed of same-day delivery are a huge win for patients, it’s important to remember that medication isn’t the same as groceries or other deliveries – even the most common and seemingly harmless drugs need careful consideration from healthcare professionals. When big retailers start handling medications like they do other consumer products, it can unintentionally reduce the medication oversight patients really need. It is already difficult enough for providers to weigh the risks and benefits of medications with existing data silos. At the same time, pharmacists do not have sufficient visibility into medications dispensed at other pharmacies to catch potential interactions. The shift toward a fast, Amazon Prime-style delivery model could make this situation even more difficult, since it's adding yet another dispensing pharmacy into the mix. We really need safeguards to make sure patients aren’t getting medications they don’t need – or worse, medications that could harm them. One of the big risks here is inappropriate polypharmacy, which happens when patients end up taking five or more medications at once. Today, about 1 in 5 adults take five or more medications; with the rate twice as much for older adults. This is a serious issue that can lead to dangerous drug interactions which put patients at risk of hospitalization and even death. When patients can conveniently refill their prescriptions and have them delivered in just a few clicks, medications can arrive without a clinician reassessing whether they’re still right for the patient. As a result, a patient could receive a drug they no longer need or even a duplicate prescription. It’s not the convenience that’s the problem, but we do need safeguards. If we don’t address this, we could see over 4.6 million additional hospitalizations and as many as 150,000 premature deaths in the US over the next decade alone. What are the potential consequences of overprescribing and polypharmacy for patients, including adverse drug interactions, increased hospitalizations, and higher healthcare costs? Yoona Kim: The risks of overprescribing and polypharmacy are well-documented and, unfortunately, very real for patients – the more drugs you’re on, the higher the chances of costly and harmful drug interactions and other consequences. Take elderly patients with heart disease – when they're on five or more medications, their healthcare costs nearly double while their pharmacy expenses triple compared to those taking fewer drugs. Patients taking five or more medications face nearly twice the risk of adverse drug events, leading to outpatient clinic or emergency room visits. This trend is especially concerning in certain disease areas such as behavioral health where we're seeing an alarming increase in polypharmacy. Currently 60% of adults with behavioral health conditions are prescribed two or more psychotropic medications, a practice that frequently leads to more emergency room visits and higher healthcare costs. Hyperpolypharmacy – when a patient is on 10 or more medications – can be even more consequential. A study found that hyperpolypharmacy remained significantly associated with an increased risk for hospitalization for any reason and any serious adverse event. Despite these risks, polypharmacy has been rising quickly. In the past two decades, the number of older adults in the US taking five or more medications has almost doubled to over 44%. Addressing polypharmacy can be tricky and there is no known structured approach given that these are patient-specific interventions with many factors to consider such as patient goals, medications used, and preferences. There are treatment guidelines for initiating treatment for almost every disease area, but not as clear in these guidelines is when to discontinue medications. Regular reviews of each patient’s medications are essential so clinicians can spot duplicates and identify any drugs that may be causing more harm than good. This way, when necessary and possible, they can work with patients on a safe plan to deprescribe – in other words, taper off these medications. But achieving that level of oversight becomes harder as the focus on convenience and rapid refills continues to grow. How does the rapid evolution of medication knowledge and drug interactions challenge healthcare providers to ensure safe and effective medication management? Yoona Kim: Medication knowledge is evolving faster than ever, which can actually be a double-edged sword for healthcare providers. Every year, dozens of new drugs get FDA approval, while existing medications gain new uses – or new warnings about potential risks. Doctors are trained on medications during medical school, but keeping up with all the updates year after year is almost impossible. This constant influx of new drugs and changing guidelines means that even the best-resourced healthcare providers can struggle to stay fully informed. There are platforms that providers can use to look up drug interactions and active ingredients, but these resources don’t account for all the individual factors that might impact how someone responds to a medication. For truly safe and effective medication management, providers need a full, up-to-date view of not only the drugs themselves but also the patient’s unique clinical, social and behavioral circumstances. Keeping track of all this information in real time is a major challenge for healthcare providers, especially as medication knowledge continues to expand. What are the potential consequences of medication mismanagement across the healthcare continuum, from primary care to hospitals and long-term care facilities? Yoona Kim: The consequences of medication mismanagement are severe across the continuum. In fact, medication-related problems are the largest area of waste in our healthcare system and 1 in every 6 healthcare dollars or $528B annually are spent on consequences from suboptimal medications. To illustrate this issue, let me share the story of two patients we’ve encountered at Arine. Patient E, a man with heart failure, diabetes, COPD, and previous hospitalizations was prescribed multiple doses of the same heart medications by different providers over two months. Every time he was hospitalized again or received a new prescription, he didn’t understand that he was supposed to stop taking the previous medication he’d been prescribed. No one noticed that he was taking multiple duplicates of 6 heart failure medications at the same time, which could have led to renal failure and cardiac arrest. Without intervention, the outcome could have been fatal. Patient P who was battling multiple heart conditions – including heart failure, atrial fibrillation, and a previous heart attack, alongside COPD and blood clotting issues – had experienced multiple hospitalizations within a year. Despite the severity of his conditions, he struggled with taking his prescribed heart and blood-thinning medications consistently and had gone nearly a year without seeing a cardiologist. He was also missing key medications necessary to better manage his condition. Without proper medication adherence, additional necessary treatments, and specialist oversight, his health was at significant risk for further decline and complications. These are just two examples, but millions of Americans face similar challenges every day. There’s a common misconception that doctors and pharmacists have full control over patients’ meds. But in reality, keeping track of everything from a patient’s full medical history to their socioeconomic challenges – like paying for meds, transportation issues or even health literacy barriers – is incredibly hard. Providers would need a complete 360-degree view of each patient’s life to get every prescription right, which is just not realistic with the current system. How can technology and AI be leveraged to enhance medication management and reduce the risks of overprescribing and polypharmacy? Yoona Kim: Using technology and AI is the only way to tackle an issue as enormous as medication management. The complexity of today’s healthcare system and the sheer volume of medication knowledge make it impossible for providers to keep track of every new guideline or patient-specific factor without the support of technology. AI can sift through massive data sets in order to connect the dots between the latest medication information and each patient’s unique health and life circumstances to recommend a safe, optimized medication plan. Can you explain how Arine's medication intelligence platform addresses the challenges of overprescribing and other forms of medication mismanagement? Yoona Kim: Our AI-powered medication intelligence platform assesses everything from optimal drug choice, drug dose, or duplication errors and harmful interactions, to socioeconomic factors that could be acting as a blocker in an otherwise sound treatment plan. These are presented to the provider as specific data-driven recommendations, including contextual information about the patient’s circumstances, and helps them make more informed decisions. In areas like overprescribing, this is essential. Our platform flags unnecessary medications that may be causing more harm than benefit and suggests deprescribing or changing medications as needed, again in the context of the full patient picture. While much of the conversation around AI in healthcare has been purely speculative, Arine’s technology offers a tangible solution to a specific problem with proven positive impacts on patient outcomes. Through medication intelligence, we were able to identify and correct the medication errors that were affecting Patient E and Patient P’s treatment plans. Patient E’s duplicative heart failure medications were deprescribed and his heart failure is much better controlled on fewer medications and lower costs. Patient P was counseled on the importance of adherence and put on a more comprehensive treatment regimen with additional heart failure medications to prevent more hospitalizations, supported by his new cardiologist. What are the key challenges and opportunities that lie ahead in addressing medication mismanagement, particularly as the paradigm of drug dispensing continues to evolve? Yoona Kim: As more retailers like Amazon move into pharmacy, there’s a big shift toward automation, and with it, both challenges and opportunities. One of the biggest concerns is the potential for automated prescription refills to create a disconnect between healthcare providers and patients. Providers need visibility to all dispensed medications and the full patient picture to properly review and prevent unnecessary negative consequences of medication errors. Patients need proper counseling as taking medications incorrectly could end up undoing the convenience that automated services are trying to provide. On the flip side, automation could actually be a major win for healthcare, especially in reducing the heavy administrative workload on doctors and pharmacists. Streamlining some of these repetitive tasks could free up their time for direct patient care, and help to prevent burnout and keep more providers in the profession. But it’s all about balance – if we’re building guardrails to ensure that the convenience at the prescription level flows all the way through to safe, efficient care, particularly leveraging AI and technology, we stand to improve patient outcomes and reduce costs. About Yoona Kim Yoona Kim is the CEO and co-founder of Arine, a next-generation medication intelligence company with a mission to solve medication mismanagement across the healthcare continuum. Arine’s proprietary platform pulls insights from a complex ecosystem of clinical, socioeconomic, and behavioral data to generate personalized care plans and deliver value-based care. Yoona previously led clinical and health economic activities at leading digital health and pharma companies including Novartis and Gilead. She also implemented innovative healthcare design and value-based insurance programs for large self-insured employers at Mercer Health and Benefits. She holds a bachelor’s degree from Stanford University, a PharmD with an emphasis in health policy and management from the University of California, San Francisco, and a PhD in health economics and outcomes from the University of Texas at Austin.

As ultra-fast prescription delivery services reshape medication access, healthcare providers face an urgent challenge: balancing patient convenience with medication safety. With 1 in 5 adults using five or more prescription drugs and medication-related problems consuming 1 in 6 healthcare dollars ($528B annually), the stakes are high. In this interview, Yoona Kim, CEO of healthcare AI company Arine discusses how the evolution of prescription delivery services, while improving access, may
Read More

UCSF and GE HealthCare Launch Care Innovation Hub to Advance Medical Imaging and Precision Medicine

by Fred Pennic 01/15/2025 Leave a Comment

UCSF and GE HealthCare Launch Care Innovation Hub to Advance Medical Imaging and Precision Medicine

What You Should Know: - The University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE HealthCare have joined forces to establish a Care Innovation Hub, a collaborative research initiative focused on addressing critical clinical challenges in medical imaging and treatment.  - The Care Innovation Hub leverages the strengths of both academia and industry to translate novel technologies into clinical practice, ultimately improving patient care
Read More

Amwell & Vida Health Partner to Expand Virtual Cardiometabolic Care Offerings

by Fred Pennic 01/15/2025 Leave a Comment

Amwell & Vida Health Partner to Expand Virtual Cardiometabolic Care Offerings

What You Should Know: - Amwell (NYSE: AMWL), a provider of digital health solutions, announced a new partnership with Vida Health, a virtual cardiometabolic care provider.  - The strategic collaboration expands Amwell's clinical program portfolio, offering a comprehensive suite of cardiometabolic care services to its extensive network of health plans and employers. Addressing the Cardiometabolic Health Crisis Over 40% of American adults struggle with obesity, a major risk factor
Read More

How Clinical Pharmacist-Led Telehealth Models Are Transforming Diabetes Care

by Cynthia Chioma Nwaubani, PharmD, BCGP, CEO and founder, PharmD Live 01/15/2025 Leave a Comment

How Clinical Pharmacist-Led Telehealth Models Are Transforming Diabetes Care

Diabetes, a chronic condition affecting millions of Americans, is on the rise. According to the CDC, 15.8% of the U.S. population now lives with diabetes. With over 38 million people managing this complex disease, effective care is essential. Yet, access to diabetes care has become increasingly challenging, especially for underserved communities. The closure of primary care clinics by major retail pharmacy chains has further strained access to care, leaving vulnerable populations without the
Read More

Truveta Genome Project to Create Largest, Most Diverse Genomic Database with AI

by Syed Hamza Sohail 01/15/2025 Leave a Comment

Truveta Genome Project to Create Largest, Most Diverse Genomic Database with AI

What You Should Know: -  Today, leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence, and Trinity Health, announce the Truveta Genome Project, an innovative collaboration to generate genetic data on tens of millions of consented and de-identified volunteers, creating the largest and most diverse database of genotypic and phenotypic information ever assembled.  -  At over ten times the scale of previous endeavors, this
Read More

25 Executive Digital Health Predictions & Trends to Watch in 2025

by Fred Pennic 01/14/2025 Leave a Comment

25 Executive Digital Health Predictions & Trends to Watch in 2025

From the rise of personalized nutrition to the growing importance of interoperability, healthcare is on the cusp of transformative change. Explore the key trends and predictions that will shape the healthcare landscape in 2025, according to 25 industry leaders. Naveen Jain, CEO and Founder of Viome "By 2025, personalized nutrition will evolve from a niche innovation to a cornerstone of mainstream wellness. Faced with escalating healthcare costs, insurers and employers will adopt
Read More

Digital Health Funding Decline in 2024: Rise of the Mega Funds

by Fred Pennic 01/14/2025 Leave a Comment

Digital Health Funding in 2024: A Year of Contrasts and Concentration

What You Should Know:  The digital health landscape in 2024 was marked by a surge in early-stage investments alongside significant moves by established healthcare giants, according to Rock Health's annual end of the year funding report.  - The Rock Health report states the "David and Goliath" phenomenon has created a complex ecosystem where both small startups and large players are vying for a share of the innovation pie. A Year of Contrasts While venture funding in U.S.
Read More

AI-Powered Imaging: Sutter Health and GE HealthCare Form Care Alliance

by Fred Pennic 01/14/2025 Leave a Comment

AI-Powered Imaging: Sutter Health and GE HealthCare Form Care Alliance

What You Should Know:  - Sutter Health and GE HealthCare announced a seven-year strategic partnership, called a Care Alliance, to enhance access to innovative imaging services and create a more seamless and coordinated experience for clinicians and patients across the Sutter Health system.  - The collaboration, one of GE HealthCare's largest enterprise strategic partnerships, will bring advanced imaging technology and digital solutions to communities throughout
Read More

Teladoc Health Joins Amazon’s Health Benefits Connector for Cardiometabolic Programs

by Fred Pennic 01/14/2025 Leave a Comment

Teladoc Health Launches Chronic Condition Management Solution

What You Should Know:  - Teladoc Health (NYSE: TDOC), a global leader in virtual care, announced a new collaboration with Amazon to improve access to its chronic condition management programs.  - The strategic partnership will allow eligible Amazon customers to seamlessly discover and enroll in Teladoc Health's programs for diabetes, hypertension, prediabetes, and weight management through Amazon's Health Benefits Connector. Addressing the Chronic Disease Burden More than
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 39
  • Go to page 40
  • Go to page 41
  • Go to page 42
  • Go to page 43
  • Interim pages omitted …
  • Go to page 720
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

5 Ways New Trump Administration Tariffs Are Impacting U.S. Healthcare Now

5 Ways Trump Administration Tariffs Are Impacting U.S. Healthcare Now

iCAD, GE HealthCare Integrate to Advance Breast Cancer Detection with AI

RadNet to Acquire iCAD for $103M in All-Stock Transaction

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |